Heron Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
ALKERMES USD 1.8M 35K 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amarin USD 308.15M 2.85M 2025-03
ANI Pharmaceuticals USD 2K 0 2025-03
Arrowhead Research USD 230K 12K 2025-03
Eisai JPY 44.99B 0 2025-03
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Insmed USD 1.82M 25K 2025-03
Ligand Pharmaceuticals USD 20K 0 2025-03
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pacira USD 47K 0 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Veracyte USD 78K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12


Heron Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.